Global Latent Tuberculosis Infection (LTBI) Testing Market Research Report 2022(Status and Outlook)


Attention: There is an updated edition available for this report.

Global Latent Tuberculosis Infection (LTBI) Testing Market Research Report 2022(Status and Outlook)

Report Overview

Latent tuberculosis (LTB), also called latent tuberculosis infection (LTBI) is when a person is infected with Mycobacterium tuberculosis, but does not have active tuberculosis. Active tuberculosis can be contagious while latent tuberculosis is not, and it is therefore not possible to get TB from someone with latent tuberculosis. The main risk is that approximately 10% of these people (5% in the first two years after infection and 0.1% per year thereafter) will go on to develop active tuberculosis. This is particularly true, and there is added risk, in particular situations such as medication that suppresses the immune system or advancing age.

A quarter of the world’s population is estimated to be infected with Mycobacterium tuberculosis. Testing for TB infection increases the probability that individuals who are identified for preventive treatment will benefit from such treatment. The tuberculin skin test (TST) and the interferon gamma release assay (IGRA) are currently used to establish the diagnosis of LTB.

The Global Latent Tuberculosis Infection (LTBI) Testing Market Size was estimated at USD 1016.40 million in 2021 and is projected to reach USD 1506.30 million by 2028, exhibiting a CAGR of 5.78% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Latent Tuberculosis Infection (LTBI) Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Latent Tuberculosis Infection (LTBI) Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Latent Tuberculosis Infection (LTBI) Testing market in any manner.

Global Latent Tuberculosis Infection (LTBI) Testing Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Qiagen

Sanofi

Oxford Immunotec

Xiamen Innodx

Thermo Fisher Scientific

Par Sterile

Bio-Rad Laboratories

Market Segmentation (by Type)

Tuberculin Skin Test (TST)

Interferon Gamma Released Assay (IGRA)

Market Segmentation (by Application)

General Hospital

Specialized Hospital

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Latent Tuberculosis Infection (LTBI) Testing Market

Overview of the regional outlook of the Latent Tuberculosis Infection (LTBI) Testing Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Latent Tuberculosis Infection (LTBI) Testing Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Latent Tuberculosis Infection (LTBI) Testing
1.2 Key Market Segments
1.2.1 Latent Tuberculosis Infection (LTBI) Testing Segment by Type
1.2.2 Latent Tuberculosis Infection (LTBI) Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Latent Tuberculosis Infection (LTBI) Testing Market Overview
2.1 Global Market Overview
2.1.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size (M USD) Estimates and Forecasts (2017-2028)
2.1.2 Global Latent Tuberculosis Infection (LTBI) Testing Sales Estimates and Forecasts (2017-2028)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Latent Tuberculosis Infection (LTBI) Testing Market Competitive Landscape
3.1 Global Latent Tuberculosis Infection (LTBI) Testing Sales by Manufacturers (2017-2022)
3.2 Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Manufacturers (2017-2022)
3.3 Latent Tuberculosis Infection (LTBI) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Latent Tuberculosis Infection (LTBI) Testing Average Price by Manufacturers (2017-2022)
3.5 Manufacturers Latent Tuberculosis Infection (LTBI) Testing Sales Sites, Area Served, Product Type
3.6 Latent Tuberculosis Infection (LTBI) Testing Market Competitive Situation and Trends
3.6.1 Latent Tuberculosis Infection (LTBI) Testing Market Concentration Rate
3.6.2 Global 5 and 10 Largest Latent Tuberculosis Infection (LTBI) Testing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Latent Tuberculosis Infection (LTBI) Testing Industry Chain Analysis
4.1 Latent Tuberculosis Infection (LTBI) Testing Industry Chain Analysis
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Latent Tuberculosis Infection (LTBI) Testing Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Latent Tuberculosis Infection (LTBI) Testing Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Type (2017-2022)
6.3 Global Latent Tuberculosis Infection (LTBI) Testing Market Size Market Share by Type (2017-2022)
6.4 Global Latent Tuberculosis Infection (LTBI) Testing Price by Type (2017-2022)
7 Latent Tuberculosis Infection (LTBI) Testing Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Sales by Application (2017-2022)
7.3 Global Latent Tuberculosis Infection (LTBI) Testing Market Size (M USD) by Application (2017-2022)
7.4 Global Latent Tuberculosis Infection (LTBI) Testing Sales Growth Rate by Application (2017-2022)
8 Latent Tuberculosis Infection (LTBI) Testing Market Segmentation by Region
8.1 Global Latent Tuberculosis Infection (LTBI) Testing Sales by Region
8.1.1 Global Latent Tuberculosis Infection (LTBI) Testing Sales by Region
8.1.2 Global Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Region
8.2 North America
8.2.1 North America Latent Tuberculosis Infection (LTBI) Testing Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Latent Tuberculosis Infection (LTBI) Testing Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Latent Tuberculosis Infection (LTBI) Testing Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Latent Tuberculosis Infection (LTBI) Testing Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profiled
9.1 Qiagen
9.1.1 Qiagen Latent Tuberculosis Infection (LTBI) Testing Basic Information
9.1.2 Qiagen Latent Tuberculosis Infection (LTBI) Testing Product Overview
9.1.3 Qiagen Latent Tuberculosis Infection (LTBI) Testing Product Market Performance
9.1.4 Qiagen Business Overview
9.1.5 Qiagen Latent Tuberculosis Infection (LTBI) Testing SWOT Analysis
9.1.6 Qiagen Recent Developments
9.2 Sanofi
9.2.1 Sanofi Latent Tuberculosis Infection (LTBI) Testing Basic Information
9.2.2 Sanofi Latent Tuberculosis Infection (LTBI) Testing Product Overview
9.2.3 Sanofi Latent Tuberculosis Infection (LTBI) Testing Product Market Performance
9.2.4 Sanofi Business Overview
9.2.5 Sanofi Latent Tuberculosis Infection (LTBI) Testing SWOT Analysis
9.2.6 Sanofi Recent Developments
9.3 Oxford Immunotec
9.3.1 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Basic Information
9.3.2 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Product Overview
9.3.3 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Product Market Performance
9.3.4 Oxford Immunotec Business Overview
9.3.5 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing SWOT Analysis
9.3.6 Oxford Immunotec Recent Developments
9.4 Xiamen Innodx
9.4.1 Xiamen Innodx Latent Tuberculosis Infection (LTBI) Testing Basic Information
9.4.2 Xiamen Innodx Latent Tuberculosis Infection (LTBI) Testing Product Overview
9.4.3 Xiamen Innodx Latent Tuberculosis Infection (LTBI) Testing Product Market Performance
9.4.4 Xiamen Innodx Business Overview
9.4.5 Xiamen Innodx Latent Tuberculosis Infection (LTBI) Testing SWOT Analysis
9.4.6 Xiamen Innodx Recent Developments
9.5 Thermo Fisher Scientific
9.5.1 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Basic Information
9.5.2 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Product Overview
9.5.3 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Product Market Performance
9.5.4 Thermo Fisher Scientific Business Overview
9.5.5 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing SWOT Analysis
9.5.6 Thermo Fisher Scientific Recent Developments
9.6 Par Sterile
9.6.1 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Basic Information
9.6.2 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Product Overview
9.6.3 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Product Market Performance
9.6.4 Par Sterile Business Overview
9.6.5 Par Sterile Recent Developments
9.7 Bio-Rad Laboratories
9.7.1 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Basic Information
9.7.2 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Product Overview
9.7.3 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Product Market Performance
9.7.4 Bio-Rad Laboratories Business Overview
9.7.5 Bio-Rad Laboratories Recent Developments
10 Latent Tuberculosis Infection (LTBI) Testing Market Forecast by Region
10.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast
10.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Country
10.2.3 Asia Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Region
10.2.4 South America Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Latent Tuberculosis Infection (LTBI) Testing by Country
11 Forecast Market by Type and by Application (2022-2028)
11.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Forecast by Type (2022-2028)
11.1.1 Global Forecasted Sales of Latent Tuberculosis Infection (LTBI) Testing by Type (2022-2028)
11.1.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Type (2022-2028)
11.1.3 Global Forecasted Price of Latent Tuberculosis Infection (LTBI) Testing by Type (2022-2028)
11.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Forecast by Application (2022-2028)
11.2.1 Global Latent Tuberculosis Infection (LTBI) Testing Sales (K Units) Forecast by Application
11.2.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Size (M USD) Forecast by Application (2022-2028)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings